Brokerage house Motilal Oswal is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 800, in its research report dated January 28, 2015.

Accumulate Ranbaxy; target Rs 780: KRChoksey

KRChoksey is bullish on Ranbaxy Laboratories and has recommended accumulate rating on the stock with a target price of Rs 780 in its January 29, 2015 research report.

Angel Broking neutral on Ranbaxy Laboratories

Angel Broking has maintained a neutral rating on Ranbaxy Laboratories, in its November 3, 2014 research report.

Accumulate Ranbaxy Labs; target of Rs 670: KRChoksey

KRChoksey is bullish on Ranbaxy Labs and has recommended accumulate rating on the stock with a target of Rs 670 in its October 29, 2014 research report.

Angel Broking neutral on Ranbaxy Laboratories

Angel Broking has maintained a 'Neutral' rating on Ranbaxy Laboratories, in its August 4, 2014 research report.

Angel Broking neutral on Ranbaxy Laboratories

Angel Broking has maintained a neutral rating on Ranbaxy Laboratories, in its May 09, 2014 research report. The research firm believes that, the stock will mirror the movements in the Sun Pharma stock.

Reduce Ranbaxy Laboratories; target Rs 417: P Lilladher

Prabhudas Lilladher has recommended a 'Reduce' rating on Ranbaxy Laboratories with a target price of Rs 417, in its January 13, 2014 research report.

Hold Ranbaxy Laboratories; target Rs 308: Emkay

Emkay Global Financial Services has recommended hold rating on Ranbaxy Laboratories with a target price of Rs 308, in its October 11, 2013 research report.

Hold Ranbaxy Laboratories; target Rs 308: Emkay

Emkay Global Financial Services has recommended hold rating on Ranbaxy Laboratories with a target price of Rs 308, in its September 25, 2013 research report.

Angel Broking neutral on Ranbaxy Laboratories

Angel Broking has recommended neutral rating on Ranbaxy Laboratories, in its September 17, 2013 report.

Angel maintains 'Neutral' rating on HDFC, Ranbaxy, GCPL

Brokerage house Angel Broking has maintained its 'Neutral' rating on Housing Development Finance Corporation (HDFC), Ranbaxy Laboratories and Godrej Consumer Products (GCPL).

Angel Broking neutral on Ranbaxy Laboratories

Angel Broking has maintained a neutral rating on Ranbaxy Laboratories (Ranbaxy) in its February 27, 2013 research report.

Hold Ranbaxy Laboratories; target Rs 400: Emkay

Emkay Global Financial Services has recommended hold rating on Ranbaxy Laboratories with a target price of Rs 400, in its February 26, 2013 research report.

Buy Ranbaxy Labs; target of Rs 530: IIFL

IIFL is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 530 in its December 5, 2012 research report.

Accumulate Ranbaxy Labs; target of Rs 579: PLilladher

Prabhudas Lilladher is bullish on Ranbaxy Labs and has recommended accumulate rating on the stock with a target of Rs 579 in its November 26, 2012 research report.

Buy Ranbaxy Labs; target of Rs 590: Emkay

Emkay Global Financial Services is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target of Rs 590 in its November 8, 2012 research report.

Accumulate Ranbaxy; target of Rs 579: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Ranbaxy Laboratories and has recommended accumulate rating on the stock with a target of Rs 579 in its November 8, 2012 research report.

Buy or sell: Emkay's trading tips for Mahurat trading

Emkay Global Financial Services has come out with its report on conviction ideas.

Buy Ranbaxy Labs; target of Rs 572: Nirmal Bang

Nirmal Bang is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 572 in its October 15 2012 research report.

Buy Ranbaxy Labs; target of Rs 559: Emkay

Emkay Global Financial Services is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target of Rs 559 in its August 9, 2012 research report.

15 stocks to buy this earning season: Emkay

Emkay Global Financial Services has come out with its report on various stocks like Cadila Healthcare, HDFC Bank, ICICI Bank etc. The research firm recommends buying this stock.

GEPL Capital picks Infosys, Ranbaxy for short sell

GEPL Capital has come out with its report on Infosys and Ranbaxy Labs.

Buy Ranbaxy Laboratories; target Rs 559: Emkay

Emkay Global Financial Services is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 559 in its May 09, 2012 research report.

Hold Ranbaxy Laboratories; target Rs 465: Unicon Investment

Unicon Investment has recommended hold rating on Ranbaxy Laboratories with a target price of Rs 465, in its February 24, 2012 research report.

Buy Ranbaxy Labs; target of Rs 504: Emkay

Emkay Global Financial Services is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 504 in its February 23, 2012 research report.